Portfolio company Anaconda Biomed secured $56 million in financing from new and existing investors.
Anaconda Biomed S
Anaconda Biomed S.L. is a Barcelona-based medical device start-up developing next-generation endovascular access and protection. The company is dedicated to reducing disability and death caused by stroke and other neurovascular diseases through innovative thrombectomy and proximal embolic protection.